Schonfeld Strategic Advisors LLC Biolife Solutions Inc Transaction History

Schonfeld Strategic Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $385,032 - $702,210	26,300 New	26,300 $598,000
Q1 2020 May 15, 2020	SELL	$8.36 - $17.03 $95,304 - $194,142	-11,400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$14.59 - $18.9 $1.07 Million - $1.38 Million	-73,000 Reduced 86.49%	11,400 $184,000
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $1.52 Million - $2.03 Million	-96,900 Reduced 53.45%	84,400 $1.4 Million
Q2 2019 Aug 14, 2019	SELL	$15.2 - $19.42 $1.43 Million - $1.82 Million	-93,900 Reduced 34.12%	181,300 $3.07 Million
Q1 2019 May 15, 2019	SELL	$10.9 - $21.26 $670,350 - $1.31 Million	-61,500 Reduced 18.27%	275,200 $4.92 Million
Q4 2018 Feb 14, 2019	SELL	$9.5 - $17.17 $302,100 - $546,006	-31,800 Reduced 8.63%	336,700 $4.05 Million
Q3 2018 Nov 14, 2018	BUY	$14.99 - $25.48 $277,315 - $471,380	18,500 Added 5.29%	368,500 $6.45 Million
Q1 2018 May 15, 2018	BUY	$4.73 - $6.03 $69,876 - $89,081	14,773 Added 4.41%	350,000 $1.8 Million
Q4 2017 Feb 14, 2018	BUY	$4.98 - $6.9 $225,230 - $312,066	45,227 Added 15.6%	335,227 $2.01 Million
Q3 2017 Nov 14, 2017	BUY	$3.45 - $5.71 $1 Million - $1.66 Million	290,000	290,000 $1.66 Million

188

45.1M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.14B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.